SCIACOVELLI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 4.941
EU - Europa 2.044
AS - Asia 1.764
AF - Africa 583
SA - Sud America 478
OC - Oceania 56
Continente sconosciuto - Info sul continente non disponibili 22
Totale 9.888
Nazione #
US - Stati Uniti d'America 4.649
IT - Italia 904
SG - Singapore 581
CN - Cina 332
BR - Brasile 323
HK - Hong Kong 228
PL - Polonia 165
SE - Svezia 96
FI - Finlandia 94
VN - Vietnam 91
DE - Germania 89
RU - Federazione Russa 81
NL - Olanda 66
FR - Francia 64
GB - Regno Unito 54
UA - Ucraina 33
ID - Indonesia 32
MX - Messico 31
AR - Argentina 28
CA - Canada 27
MU - Mauritius 26
IN - India 25
ZA - Sudafrica 25
EC - Ecuador 24
ES - Italia 23
IQ - Iraq 23
PT - Portogallo 23
RO - Romania 23
TN - Tunisia 23
JP - Giappone 22
MA - Marocco 22
CI - Costa d'Avorio 21
GR - Grecia 21
LC - Santa Lucia 20
TR - Turchia 20
AO - Angola 19
ET - Etiopia 19
LA - Repubblica Popolare Democratica del Laos 19
MN - Mongolia 19
NI - Nicaragua 19
PE - Perù 19
PS - Palestinian Territory 19
AT - Austria 18
CG - Congo 18
EG - Egitto 18
IE - Irlanda 18
UG - Uganda 18
YE - Yemen 18
AE - Emirati Arabi Uniti 17
BF - Burkina Faso 17
CU - Cuba 17
GN - Guinea 17
HU - Ungheria 17
TZ - Tanzania 17
ZW - Zimbabwe 17
AZ - Azerbaigian 16
DO - Repubblica Dominicana 16
DZ - Algeria 16
GT - Guatemala 16
KR - Corea 16
NO - Norvegia 16
PH - Filippine 16
RW - Ruanda 16
BA - Bosnia-Erzegovina 15
BJ - Benin 15
CH - Svizzera 15
IS - Islanda 15
KE - Kenya 15
KG - Kirghizistan 15
LB - Libano 15
LU - Lussemburgo 15
LY - Libia 15
MG - Madagascar 15
PA - Panama 15
PY - Paraguay 15
SK - Slovacchia (Repubblica Slovacca) 15
TH - Thailandia 15
UY - Uruguay 15
AL - Albania 14
AM - Armenia 14
BE - Belgio 14
BS - Bahamas 14
GE - Georgia 14
ME - Montenegro 14
NC - Nuova Caledonia 14
TJ - Tagikistan 14
UZ - Uzbekistan 14
VE - Venezuela 14
ZM - Zambia 14
BY - Bielorussia 13
BZ - Belize 13
CR - Costa Rica 13
CW - ???statistics.table.value.countryCode.CW??? 13
CZ - Repubblica Ceca 13
HN - Honduras 13
JO - Giordania 13
ML - Mali 13
MY - Malesia 13
NP - Nepal 13
PK - Pakistan 13
Totale 9.319
Città #
Fairfield 796
Woodbridge 484
Ashburn 401
Singapore 370
Houston 340
Ann Arbor 292
Cambridge 291
Chandler 270
Seattle 267
Wilmington 248
Hong Kong 215
Bytom 141
Boardman 96
Princeton 92
Santa Clara 89
Beijing 87
Milan 81
San Diego 80
Medford 63
Helsinki 48
Rome 48
Padova 45
Nanjing 43
Des Moines 42
Roxbury 41
Jacksonville 40
Los Angeles 40
Ho Chi Minh City 27
Chicago 25
São Paulo 22
Bologna 21
Castries 20
Florence 20
Jinan 20
Abidjan 19
Managua 18
Munich 18
Vientiane 18
Conakry 17
Hebei 17
Kampala 17
Baku 16
Harare 16
Kigali 16
Ulan Bator 16
Buffalo 15
Dar es Salaam 15
Havana 15
London 15
Naples 15
New York 15
Antananarivo 14
Dong Ket 14
Dublin 14
Lusaka 14
Montevideo 14
Nanchang 14
Noumea 14
Panama City 14
Shenyang 14
Amman 13
Cotonou 13
Dakar 13
Luanda 13
Nairobi 13
Nassau 13
Ouagadougou 13
Trento 13
Bishkek 12
Dushanbe 12
Hanoi 12
Luxembourg 12
Niamey 12
San José 12
Tashkent 12
Venezia 12
Bamako 11
Genoa 11
Kingstown 11
Phnom Penh 11
Pieve a Nievole 11
Rio de Janeiro 11
Banjul 10
Brasília 10
Bridgetown 10
Dallas 10
Dili 10
Guatemala City 10
Johannesburg 10
Lisbon 10
Maputo 10
Port Louis 10
Port Moresby 10
Reykjavik 10
Sanaa 10
Tbilisi 10
Warsaw 10
Willemstad 10
Yerevan 10
Berlin 9
Totale 6.054
Nome #
“Modello di indicatori di qualità” dell’IFCC WG-LEPS: Risultati ed evoluzione del progetto. 506
Indicatori di Qualità nei Point Of Care Testing (POCT): Sono efficaci? 504
Quality indicators to detect pre-analytical errors in laboratory testing 185
Harmonization of pre-analytical quality indicators. 176
An Italian External Quality Assessment (EQA) program on urinary sediment. 170
What information on measurement uncertainty should be communicated to clinicians, and how? 169
A pilot study for establishing quality indicators in molecular diagnostics according to the IFCC WG-LEPS initiative: Preliminary findings in China 168
An integrated system for monitoring the quality of sample transportation. 164
Decision Support and Patient Safety 164
External Quality Assessment: an effective tool for Clinical Governance in Laboratory Medicine 163
High-performance liquid chromatography for cyclosporin measurement: comparison with radioimmunoassay 162
Assessment of package inserts for diagnostic kits. 162
The pathway for introducing novel examination procedures in routine practice in accordance with ISO 15189:2012: 17-Hydroxy progesterone, dehydroepiandrosterone sulphate and vitamin D as examples 160
Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity 160
Performance criteria and quality indicators for the pre-analytical phase. 158
Validation model of a laboratory-developed method for the ISO15189 accreditation: The example of salivary cortisol determination 156
Extra-analytical sources of uncertainty: which ones really matter? 150
A rapid, specific enzyme immunoassay for follitropin and lutropin determination. 149
Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics 148
Measurement uncertainty in laboratory reports: A tool for improving the interpretation of test results 145
Reply to W.G. Wood. Questionable results - who directs the EQAS organisers? Clin Chem Lab Med 2004;42:1073 143
Reference intervals: Are interlaboratory differences appropriate? 142
Quality indicators for laboratory diagnostics: consensus is needed. 141
External quality assessment for biochemical markers of myocardial damage: an Italian experience. 139
Interpretative comments and reference ranges in EQA programs as a tool for improving laboratory appropriateness and effectiveness 138
Monitoring skeletal cancer metastases with the bone isoenzyme of tissue unspecific alkaline phosphatase. 137
Assessment and monitoring of agreement among professionals for morphological evaluation in compliance with International accreditation standard requirements 135
IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study 135
Quality of plasma samples and BD Vacutainer Barricor tubes: Effects of centrifugation 135
Evidence on clinical relevance of cardiovascular risk evaluation in the general population using cardio-specific biomarkers 134
High-sensitivity cardiac troponin I and T methods for the early detection of myocardial injury in patients on chemotherapy 132
Protocollo operativo per la verifica della comparabilità dei risultati di laboratorio ottenuti su più procedure analitiche 129
External Quality Assessment Schemes: need for recognised requirements 128
Analytical and clinical performances of a SARS-CoV-2 S-RBD IgG assay: Comparison with neutralization titers 128
The silk road to total quality in Laboratory Medicine 127
Risk management in laboratory medicine: quality assurance programs and professional competence. 126
Appropriateness of cholesterol and triglycerides reporting checked by External Quality Assessment programs 126
Preanalytical challenges - time for solutions 126
The use of extra-analytical phase quality indicators by clinical laboratories: The results of an international survey 124
Defining a roadmap for harmonizing quality indicators in Laboratory Medicine: A consensus statement on behalf of the IFCC Working Group "laboratory Error and Patient Safety" and EFLM Task and Finish Group "performance specifications for the extra-analytical phases" 124
Performance specifications of critical results management 123
Quality specifications in EQA schemes: from theory to practice 121
Once upon a time: A tale of ISO 15189 accreditation 121
Effects of sample transportation on commonly requested laboratory tests. 119
Measurement uncertainty: Light in the shadows 118
QUALITY INDICATORS IN LABORATORY MEDICINE: THE EXPERIENCE OF A LARGE LABORATORY 116
Different approaches for estimating measurement uncertainty: An effective tool for improving interpretation of results 116
Diagnostic performances and thresholds: the key to harmonization in serological SARS-CoV-2 assays? 116
Precipitation method for separating and quantifying bone and liver alkaline phosphatase isoenzymes. 115
External quality assessment programs in the context of ISO 15189 accreditation 114
Evaluation of an ELISA for SARS-CoV-2 antibody testing: Clinical performances and correlation with plaque reduction neutralization titer 113
La consulenza del Laboratorio nella gestione del Point Of Care Testing (POCT). 112
Use of high-sensitivity cardiac troponins in the emergency department for the early rule-in and rule-out of acute myocardial infarction without persistent ST-segment elevation (NSTEMI) in Italy Expert opinion document from the Study Group of Cardiac Biomarkers associated to the Italian Societies ELAS (European Ligand Assay Society, Italy Section), SIBIoC (Società Italiana di Biochimica Clinica), and SIPMeL (Società Italiana di Patologia Clinica e Medicina di Laboratorio) 111
Extra-analytical quality indicators and laboratory performances 110
Harmonization of units and reference intervals of plasma proteins: State of the art from an External Quality Assessment Scheme 108
Post-standardization of routine creatinine assays: are they suitable for clinical applications 105
Critical laboratory results: communication is just one of the problems. 98
Extra-analytical quality indicators - Where to now? 97
Serum bone alkaline phosphatase in the follow-up of skeletal metastases. 96
POINT OF CARE TESTING (POCTS): THE IMPORTANCE OF CRITICAL PROBLEMS REPORTING 94
Towards the rational utilization of SARS-CoV-2 serological tests in clinical practice 93
Serological diagnostic for SARS-CoV-2: An experimental External Quality Assessment Scheme 93
Quality Indicators for the Total Testing Process 91
Laboratory-related errors: you cannot manage what you don't measure. You manage what you know and measure 91
APPROPRIATENESS OF CLINICAL REQUEST: IS IT POSSIBLE TO MEASURE IT? 90
Garantire la comparabilità dei risultati nel rispetto dei requisiti di qualità e delle esigenze organizzative: l’esempio di una procedura operativa 86
Innovative software for recording preanalytical errors in accord with the IFCC quality indicators 85
Importance of control materials in quality assessment of cyclosporine determination. 84
IFCC project “Model of quality indicators”: a method for results evaluation 84
The standardization of plasma protein checked by an external quality assessment scheme (EQAS) 82
Commutability of external quality assessment materials for point-of-care glucose testing using the Clinical and Laboratory Standards Institute and International Federation of Clinical Chemistry approaches 78
Quality indicators to detect pre-analytical errors: a lighthouse in the night. 75
Multicentric evaluation of the variability of digital morphology performances also respect to the reference methods by optical microscopy 67
Pre-analytical quality indicators in laboratory medicine: Performance of laboratories participating in the IFCC working group “Laboratory Errors and Patient Safety” project 64
Totale 9.954
Categoria #
all - tutte 30.961
article - articoli 27.912
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.873


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021647 0 0 0 0 33 80 39 72 133 52 82 156
2021/20221.067 57 101 158 67 23 85 59 109 45 40 110 213
2022/2023693 149 49 31 47 115 66 17 60 80 24 38 17
2023/2024474 26 41 45 45 37 30 63 22 27 17 55 66
2024/20251.639 16 106 70 79 213 34 118 113 135 68 288 399
2025/20262.925 227 564 938 1.123 73 0 0 0 0 0 0 0
Totale 9.954